|
“ "The Capital-E team are seasoned semiconductor investors whose experience, energy and networks have been invaluable in helping Movidius to hone our business strategy, attract new investors, and advance relationships with key players in our market. For an early stage semiconductor company, I'd definitely recommend approaching Capital-E." Sean Mitchell, CEO of Movidius ” |
| TRINEAN |
|
Trinean is an IMEC/UGhent spin-off that provides small volume and high throughput solutions for measurement applications in the life science industry. The company commercializes the first µL micro-plate reader for bio-molecule quantification (DNA, RNA...) with an extension to other future applications such as physico-chemical testing and enzyme assays. Responsible: Marc Wachsmuth |
